We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSMM
4876
DELISTED
Invesco BulletShares 2022 Municipal Bond ETF
BSMM
$7K ﹤0.01%
+257
New +$6.5K
ASZ
4877
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$7K ﹤0.01%
751
+167
+29% +$1.64K
TPGY
4878
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
$7K ﹤0.01%
754
+211
+39% +$2.09K
SLCRU
4879
DELISTED
Silver Crest Acquisition Corporation Unit
SLCRU
$7K ﹤0.01%
745
SMED
4880
DELISTED
Sharps Compliance Corp
SMED
$7K ﹤0.01%
2,436
+644
+36% +$2.69K
SRAX
4881
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$7K ﹤0.01%
1,963
+654
+50% +$2.42K
CEMI
4882
DELISTED
Chembio diagnostics, Inc.
CEMI
$7K ﹤0.01%
11,073
+3,791
+52% +$2.52K
QIWI
4883
DELISTED
QIWI PLC
QIWI
$7K ﹤0.01%
1,416
LJPC
4884
DELISTED
La Jolla Pharmaceutical Company
LJPC
$7K ﹤0.01%
2,083
-1,486
-42% -$5.79K
INTZ
4885
DELISTED
INTRUSION INC NEW
INTZ
$7K ﹤0.01%
1,895
-1,166
-38% -$4.31K
ABVC icon
4886
ABVC BioPharma
ABVC
$24.9M
$6K ﹤0.01%
+600
New +$12.1K
ADCT icon
4887
ADC Therapeutics
ADCT
$134M
$6K ﹤0.01%
700
-37
-5% -$350
AMBP icon
4888
Ardagh Metal Packaging
AMBP
$3.16B
$6K ﹤0.01%
982
-734
-43% -$4.96K
ASRV icon
4889
AmeriServ Financial
ASRV
$85M
$6K ﹤0.01%
1,582
-386
-20% -$1.54K
LONA
4890
LeonaBio Inc
LONA
$73.9M
$6K ﹤0.01%
189
+51
+37% +$4.67K
ATXS
4891
DELISTED
Astria Therapeutics
ATXS
$6K ﹤0.01%
2,073
+1,666
+409% +$7.47K
FABC
4892
Fabric.AI Inc
FABC
$18.3M
$6K ﹤0.01%
56
+8
+17% +$1.03K
BBGI icon
4893
Beasley Broadcasting Group
BBGI
$44.7M
$6K ﹤0.01%
239
-168
-41% -$5.17K
BEAT icon
4894
Heartbeam
BEAT
$32.7M
$6K ﹤0.01%
5,327
+2,178
+69% +$3.27K
BIV icon
4895
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$6K ﹤0.01%
80
BIVI icon
4896
BioVie
BIVI
$11.8M
$6K ﹤0.01%
42
+34
+425% +$10.2K
CASI
4897
DELISTED
CASI Pharmaceuticals
CASI
$6K ﹤0.01%
2,057
+1,848
+884% +$8.03K
CBUS icon
4898
Cibus
CBUS
$145M
$6K ﹤0.01%
487
+343
+238% +$7.23K
CIFR icon
4899
Cipher Digital
CIFR
$6.9B
$6K ﹤0.01%
4,731
+4,431
+1,477% +$10.8K
CMCM
4900
Cheetah Mobile
CMCM
$94.7M
$6K ﹤0.01%
1,657
+1,251
+308% +$5.05K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.